Skip to main content

CORRECTION article

Front. Immunol., 16 November 2021
Sec. Cancer Immunity and Immunotherapy
Volume 12 - 2021 | https://doi.org/10.3389/fimmu.2021.808492

Corrigendum: NLRP3 Inflammasome Promotes the Progression of Acute Myeloid Leukemia via IL-1β Pathway

This article is a correction to:

  1. NLRP3 Inflammasome Promotes the Progression of Acute Myeloid Leukemia via IL-1β Pathway

    1. Read original article
Chaoqin Zhong,&#x;Chaoqin Zhong1,2†Ruiqing Wang&#x;Ruiqing Wang1†Mingqiang Hua,&#x;Mingqiang Hua1,3†Chen ZhangChen Zhang1Fengjiao HanFengjiao Han1Miao XuMiao Xu1Xinyu YangXinyu Yang1Guosheng LiGuosheng Li1Xiang HuXiang Hu1Tao SunTao Sun1Chunyan JiChunyan Ji1Daoxin Ma*Daoxin Ma1*
  • 1Department of Hematology, Qilu Hospital of Shandong University, Jinan, China
  • 2Department of Hematology, Shandong Yantai Mountain Hospital, Yantai, China
  • 3Department of Emergency, Qilu Hospital of Shandong University, Jinan, China

A Corrigendum on:
NLRP3 Inflammasome Promotes the Progression of Acute Myeloid Leukemia via IL-1β Pathway

By Zhong C, Wang R, Hua M, Zhang C, Han F, Xu M, Yang X, Li G, Hu X, Sun T, Ji C and Ma D (2021). Front. Immunol. 12:661939. doi: 10.3389/fimmu.2021.661939

An author name was incorrectly spelled as Chaoqing Zhong. The correct spelling is Chaoqin Zhong.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: inflammasome, NLRP3, IL-1β, acute myeloid leukemia, progression

Citation: Zhong C, Wang R, Hua M, Zhang C, Han F, Xu M, Yang X, Li G, Hu X, Sun T, Ji C and Ma D (2021) Corrigendum: NLRP3 Inflammasome Promotes the Progression of Acute Myeloid Leukemia via IL-1β Pathway. Front. Immunol. 12:808492. doi: 10.3389/fimmu.2021.808492

Received: 03 November 2021; Accepted: 04 November 2021;
Published: 16 November 2021.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2021 Zhong, Wang, Hua, Zhang, Han, Xu, Yang, Li, Hu, Sun, Ji and Ma. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Daoxin Ma, daoxinma@sdu.edu.cn

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.